What is the equity of VolitionRX this year?
VolitionRX has equity of -24.91 M USD this year.
VolitionRX Equity 2025
VolitionRX Equity
-24.91 M USD
Ticker
VNRX
ISIN
US9286611077
WKN
A12B6K
In 2025, VolitionRX's equity was -24.91 M USD, a 219.23% increase from the -7.8 M USD equity in the previous year.
VolitionRX Aktienanalyse
What does VolitionRX do?
VolitionRX Ltd was founded in 2010 with headquarters in Austin, Texas. It is a multinational life science company specializing in the discovery of cancer and other disease markers. The company's mission is to improve the quality of life for millions of people worldwide through the development of pain diagnostic systems. History VolitionRX began as a collaboration between scientists Professor Avraham Rasooly from the University of California and Professor David Kroll from North Carolina State University. The two professors were searching for a more effective diagnostic method for cancer and eventually co-founded VolitionRX in 2010. Initially, the company focused on developing diagnostic tests for stomach and colorectal cancer. Business model VolitionRX is a research-based company that specializes in the development of diagnostic and testing systems for cancer. The company works closely with leading cancer experts and scientific institutions to achieve groundbreaking research results. The goal is to develop innovative diagnostic methods that enable doctors to detect cancer faster and more effectively. Divisions VolitionRX is divided into three main areas: diagnostic tests, research and development, and partner and customer relations. Diagnostic tests VolitionRX offers a variety of diagnostic tests for cancer and other diseases. The tests are based on nucleosomics technology, which allows for analysis of cellular DNA. VolitionRX has developed various tests for colorectal cancer, lung cancer, pancreatic cancer, and other types of cancer, and is working on new tests for other conditions. Research and development VolitionRX continuously invests in research and development of new diagnostic methods for cancer and other diseases. The company collaborates closely with leading scientific institutions and cancer experts to develop innovative solutions for cancer diagnostics. Partner and customer relations VolitionRX works with a range of partners to distribute its diagnostic tests worldwide. The company has partnerships with various diagnostic laboratories and medical institutions to make its tests available to a wider target audience. Products VolitionRX offers a variety of products for the diagnosis of cancer and other diseases. These include: 1. NuQ blood tests for the diagnosis of colorectal cancer and other types of cancer. 2. Nucleosomics technology for analysis of cellular DNA for early cancer detection. 3. Software for data analysis from medical tests. Future prospects VolitionRX aims to further improve its technology for cancer diagnosis in order to save lives and improve the quality of life for people worldwide. The company's future prospects are promising as the demand for fast and effective cancer diagnostic methods continues to increase due to the rising number of cancer cases worldwide. VolitionRX ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing VolitionRX's Equity
VolitionRX's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding VolitionRX's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating VolitionRX's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
VolitionRX's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in VolitionRX’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about VolitionRX stock
What was the equity of VolitionRX compared to the previous year?
The equity of VolitionRX has increased/decreased by 219.23% increased compared to the previous year.
What impact does a high equity have on investors of VolitionRX?
A high equity is advantageous for investors of VolitionRX as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of VolitionRX?
A low equity can be a risk for investors of VolitionRX, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of VolitionRX affect the company?
An increase in equity of VolitionRX can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of VolitionRX affect the company?
A reduction in equity of VolitionRX can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of VolitionRX?
Some factors that can affect the equity of VolitionRX include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of VolitionRX so important for investors?
The equity of VolitionRX is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can VolitionRX take to change the equity?
To change equity, VolitionRX can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does VolitionRX pay?
Over the past 12 months, VolitionRX paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, VolitionRX is expected to pay a dividend of 0 USD.
What is the dividend yield of VolitionRX?
The current dividend yield of VolitionRX is .
When does VolitionRX pay dividends?
VolitionRX pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of VolitionRX?
VolitionRX paid dividends every year for the past 0 years.
What is the dividend of VolitionRX?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is VolitionRX located?
VolitionRX is assigned to the 'Health' sector.
Wann musste ich die Aktien von VolitionRX kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of VolitionRX from 8/5/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/5/2025.
When did VolitionRX pay the last dividend?
The last dividend was paid out on 8/5/2025.
What was the dividend of VolitionRX in the year 2024?
In the year 2024, VolitionRX distributed 0 USD as dividends.
In which currency does VolitionRX pay out the dividend?
The dividends of VolitionRX are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von VolitionRX
Our stock analysis for VolitionRX Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of VolitionRX Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
